Neximmune: Leading CGT Supplier for Innovative Solutions
Neximmune, a groundbreaking product from T&L Biotechnology Co., Ltd., is revolutionizing the landscape of immunotherapy. Designed to enhance the body’s own immune response, Neximmune utilizes proprietary technology to engineer T cells that target and eliminate diseased cells efficiently. This innovative approach aims to provide personalized treatment options for various cancers and Infectious Diseases, minimizing side effects while maximizing therapeutic efficacy
- High-Quality Strep Magnetic Beads
- Custom Gene Therapy Viral Vectors
- Custom Protein Interface Analysis
- Cell-Based Gene Therapies Service
- Cell Culture Media Filter Service
- Gmp-Grade Culture Media Suppliers
- Custom Car-T Technology Platforms
- Car-T Process Validation Supplier
- Magnetic Coloured Beads Suppliers
- High-Quality Cell Culture Systems